Predicting adverse drug reactions through interpretable deep learning framework
暂无分享,去创建一个
[1] Inci M. Baytas,et al. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence , 2018, Scientific Reports.
[2] Alán Aspuru-Guzik,et al. Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules , 2016, ACS central science.
[3] Avi Ma'ayan,et al. Drug-induced adverse events prediction with the LINCS L1000 data , 2016, Bioinform..
[4] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[5] Gang Fu,et al. PubChem Substance and Compound databases , 2015, Nucleic Acids Res..
[6] Dongsheng Cao,et al. Integrating Multiple Evidence Sources to Predict Adverse Drug Reactions Based on a Systems Pharmacology Model , 2015, CPT: pharmacometrics & systems pharmacology.
[7] Jimmy Ba,et al. Adam: A Method for Stochastic Optimization , 2014, ICLR.
[8] Quan Xu,et al. ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms , 2014, Nucleic Acids Res..
[9] Ping Zhang,et al. Exploring the associations between drug side-effects and therapeutic indications , 2014, J. Biomed. Informatics.
[10] Sergio E. Wong,et al. Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines , 2014, PloS one.
[11] Yoshua Bengio,et al. Neural Machine Translation by Jointly Learning to Align and Translate , 2014, ICLR.
[12] Jun Hu,et al. Determining molecular predictors of adverse drug reactions with causality analysis based on structure learning , 2014, J. Am. Medical Informatics Assoc..
[13] Ping Zhang,et al. Exploring the Relationship Between Drug Side-Effects and Therapeutic Indications , 2013, AMIA.
[14] Pierre Baldi,et al. Deep Architectures and Deep Learning in Chemoinformatics: The Prediction of Aqueous Solubility for Drug-Like Molecules , 2013, J. Chem. Inf. Model..
[15] N. Shah,et al. Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.
[16] Patrick Aloy,et al. Analysis of chemical and biological features yields mechanistic insights into drug side effects. , 2013, Chemistry & biology.
[17] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[18] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[19] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[20] P. Bork,et al. Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.
[21] A. Butte,et al. Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data , 2011, Clinical pharmacology and therapeutics.
[22] Yoshihiro Yamanishi,et al. Predicting drug side-effect profiles: a chemical fragment-based approach , 2011, BMC Bioinformatics.
[23] Eunok Paek,et al. High-throughput peptide quantification using mTRAQ reagent triplex , 2011, BMC Bioinformatics.
[24] C Helma,et al. Prediction of Adverse Drug Reactions Using Decision Tree Modeling , 2010, Clinical pharmacology and therapeutics.
[25] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[26] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[27] Bin Chen,et al. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..
[28] Christopher D. Manning,et al. Introduction to Information Retrieval , 2008, J. Assoc. Inf. Sci. Technol..
[29] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[30] Rajarshi Guha,et al. Chemical Informatics Functionality in R , 2007 .
[31] D. Bojanic,et al. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.
[32] Daniel T. Larose,et al. Discovering Knowledge in Data: An Introduction to Data Mining , 2005 .
[33] A. Grizzle,et al. Drug-related morbidity and mortality: updating the cost-of-illness model. , 2001, Journal of the American Pharmaceutical Association.
[34] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[35] George M. Church,et al. Biclustering of Expression Data , 2000, ISMB.
[36] William DuMouchel,et al. Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .
[37] E. Brown,et al. The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.
[38] J. Sibley,et al. Avascular necrosis of the hips following longterm use of clobetasol propionate. , 1986, Journal of the American Academy of Dermatology.
[39] H. L. Morgan. The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service. , 1965 .
[40] Vít Novácek,et al. Using Drug Similarities for Discovery of Possible Adverse Reactions , 2016, AMIA.
[41] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[42] Matthew Crosby,et al. Association for the Advancement of Artificial Intelligence , 2014 .
[43] Arlindo L. Oliveira,et al. Biclustering algorithms for biological data analysis: a survey , 2004, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[44] Trevor Hastie,et al. The Elements of Statistical Learning , 2001 .
[45] Ah Chung Tsoi,et al. Face recognition: a convolutional neural-network approach , 1997, IEEE Trans. Neural Networks.
[46] Alexander J. Smola,et al. Neural Information Processing Systems , 1997, NIPS 1997.